Veradigm (NASDAQ:MDRX) Shares Gap Up – Still a Buy?

Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price gapped up prior to trading on Wednesday. The stock had previously closed at $4.75, but opened at $4.9750. Veradigm shares last traded at $4.9750, with a volume of 100 shares traded.

Veradigm Trading Up 4.8%

The firm has a market cap of $609.05 million, a P/E ratio of 23.25 and a beta of 0.51. The business’s 50-day moving average is $4.88 and its two-hundred day moving average is $4.75.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc (NASDAQ:MDRX), formerly known as Allscripts Healthcare Solutions, is a healthcare technology company that provides software, data and connectivity solutions for healthcare organizations, physicians, patients, payers and life sciences companies. The company changed its name to Veradigm in 2023 to reflect its broader focus on using healthcare data to support clinical, operational and commercial decision-making.

Veradigm’s offerings include electronic health record and practice-management solutions, electronic prescribing, revenue-cycle and financial management tools, patient engagement services and healthcare information-exchange capabilities.

Read More

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.